Among the published reports, GBP2 has been shown to be a mediator of tumor (Yu et al., 2020) and intracellular immunity (Ma et al., 2008; Traver et al., 2011; Kotov et al., 2019). The gene discussed is GBP2; the disease is neoplasm.